Published • loading... • Updated
Switching HIV Regimens to Newer Drugs Tied to Weight Gain and Metabolic
Summary by Scienmag: Latest Science and Health News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGSwitching HIV Regimens to Newer Drugs Tied to Weight Gain and Metabolic
A three-year retrospective study of 2,379 people with HIV in China found that switching from older antiretroviral therapy to INSTI-based regimens drove significant weight gain and metabolic changes, with bictegravir-based therapy showing a worse profile than dolutegravir two-drug treatment.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
